Meridian Bioscience Posts 13 Percent Uptick in Q4 Revenues; 9 Percent FY13 Growth | GenomeWeb

NEW YORK (GenomeWeb News) — Meridian Bioscience today reported a 13 percent year-over-year increase in fiscal fourth quarter revenues and a 9 percent spike in full-year fiscal 2013 revenues.

For the three months ended Sept. 30, the Cincinnati, Ohio-based life science and clinical diagnostics firm reported fiscal Q4 revenues of $49 million, compared to $43.5 million in the year-ago period. Total FY2013 revenues were $188.7 million compared to $172.7 million in FY 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.